Tumor inhibitory activity of anti-ras ribozymes delivered by retroviral gene transfer

Cancer Gene Therapy

Volumn 3, Issue 4, 1996, Pages 221-229

  Li, Mingxia ^a  

^a PFIZER INC   (United States)

Author keywords

Gene transfer; Oncogene; Retroviral vector; Ribozyme

Indexed keywords

RIBOZYME;

ANIMAL; ARTICLE; CELL DIVISION; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; MOUSE; NEOPLASM; NUDE MOUSE; ONCOGENE RAS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RAT; RETROVIRUS;

3T3 CELLS; ANIMALS; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENES, RAS; MICE; MICE, NUDE; NEOPLASMS; POLYMERASE CHAIN REACTION; RATS; RETROVIRIDAE; RNA, CATALYTIC;

EID: 0030179370     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Tabin CJ, Bradley SM, Bargmann CI, et al. Mechanism of activation of a human oncogene. Nature. 1982;300:143-149.
2. Reddy EP, Reynold RK, Santos E, Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature. 1982;300:149-152.